Is Latisse Trending?
Google search interest for Latisse worldwide, tracked over the last five years.
Search interest: Latisse
What the data shows
Search interest in Latisse has fallen over the period: the yearly high moved from 100 in 2021 to 55 in 2025, against an all-time high of 100 in June 2021.
- Peak interest: June 2021 (index 100)
- Recent level (last 12 weeks): index 43 of 100
- Change, first vs. latest 12 months: -27%
- Period covered: February 2021 – January 2026
Values are Google's relative search index, where 100 is the highest point in the period — not absolute search volume.
About Latisse
Latisse is a prescription treatment for hypotrichosis (thin lashes) containing bimatoprost; applied to lashes to promote growth.
Latisse gains search interest from consumers seeking lash growth solutions; interest correlates with lash trends and telehealth access.
The brand faces competition from OTC alternatives like Grande Lash; interest remains tied to prescription and professional channels.
Official website: latisse.com
Stock market exposure
Latisse belongs to AbbVie (NYSE: ABBV). It is a small part of a much larger company, so its search trend says little about the stock on its own. An Allergan Aesthetics product. All listed companies →
As of October 2026. For information only, not investment advice — see the disclaimer.
More in Others
Compare Latisse with other others trends.
Browse Others trends →